Saxenda

Latest four-week snapshot through 2026-08-05 · 1 wave. Use the controls above to change the window.

GLP-1 Medications · 1 wave · n=72 answers, pooled

By assistant

How often each assistant brings the brand up in recommendation answers.

Share of recommendations over time

Wave-by-wave share of recommendation answers that named this brand.

What they call it

Recurring descriptions in the assistants' own words, grouped by theme.

• daily injection ×31

  “Because it is a generic, it contains the exact same active ingredient and is administered as a daily injection.”

• weight loss ×10

  “* **Generic Liraglutide:** Liraglutide is the active ingredient in brand-name Victoza (for Type 2 diabetes) and Saxenda (for weight loss).”

• approved for weight loss ×4

  “Liraglutide was the first-generation daily GLP-1 injection approved for weight loss.”

• brand name ×4

  “Without insurance, brand-name Saxenda (liraglutide) can be exceptionally expensive, often costing between $1,300 and $1,500+ per month.”

• budget-friendly ×4

  “It is priced roughly 30% lower than its brand-name counterpart, making it a highly viable, more budget-friendly daily injection alternative.”

• fda-approved ×4

  “Since it's off-label for that purpose anyway, it may be worth discussing Saxenda (the FDA-approved, higher-dose version) or newer agents like Wegovy/Zepbound with your doctor instead.”

• glp-1 receptor agonist ×4

  “FDA-Approved Generic GLP-1 Medications (Same Drug Class)”

• less weight loss ×4

  “| **Daily injection** and generally less weight loss than Zepbound/Wegovy.”

• chronic weight management ×3

  “0 mg dose specifically for chronic weight management).”

• first generic glp-1 ×3

  “* **Generic Saxenda (Liraglutide):** In late 2025, the FDA approved and Teva Pharmaceuticals launched the first-ever generic GLP-1 specifically indicated for chronic weight management.”

In their words

85 exact quoted mentions in this snapshot, grouped by coded tone.

What they recommend

“**Saxenda** – daily injection, approved for weight management”

“Saxenda (liraglutide) is a daily injection and is generally less convenient; it may be considered when the weekly options are unsuitable or unavailable.”

“Ask your doctor about **generic Saxenda or generic Victoza (liraglutide)**. These became available as the first FDA-approved generic GLP-1s. Because they are generics, insurance plans are much more likely to place them on their lowest-cost ”

“people who lost significant weight while taking Ozempic, Wegovy, Mounjaro, or Saxenda had sharply lower risks of major obesity-related health problems, including sleep apnea and kidney disease.”

“brand-name options like Victoza are on the lower end of retail pricing at roughly $900 per month”

Where they hedge

“**Saxenda** – for weight loss”

“**Saxenda** (liraglutide) – daily injection (older option)”

“**Saxenda** (liraglutide) – daily injection, older option”

“**Liraglutide** – sold as Victoza (diabetes) and Saxenda (weight loss); daily injection”

“**Saxenda** (liraglutide) – daily injection”

What they warn about

“**Saxenda is not a cheaper alternative** in practice: it is also liraglutide but marketed/dosed for weight management, not as a budget substitute for Victoza.”

The substitution map

Which competitors assistants suggest when shoppers ask for something cheaper.

Where this comes from

19 of 85 mentions appear alongside an identifiable web citation. Citation does not establish causation.

Where they send you

Stores and sites assistants name as places to buy this brand.

Method: fixed shopper questions asked repeatedly to Claude, OpenAI GPT and Gemini with web search on. Shares are the percentage of recommendation answers mentioning the brand. Quotes are AI outputs; full transcripts are kept as receipts.